口服固体製剂(OSD) 产业的成长机会

个人化医疗与药物传递技术提升未来成长潜力

该分析提供了口服固体製剂（OSD）行业的概述和进展，包括对当前行业情景、竞争格局和监管环境的评估。分析范围主要集中在北美 (NA)、欧洲、亚太地区 (APAC)、中东和拉丁美洲 (LATAM)。我们确定普及和新兴的经营模式经营模式，以帮助行业相关人员增强竞争力和提供服务。它揭示了该行业在关键驱动因素和限制因素、合作伙伴关係、投资和整合活动、颠覆性技术、近期辅料进展以及当前和未来趋势方面的成长潜力。行业用例可以让您快速了解致力于开发颠覆性技术和以患者为中心的药物的改变游戏规则的公司。它还有助于根据大趋势、经营模式、临床需求、用例、打入市场策略和技术趋势来发现成长机会。

目录

影响 OSD 配方生长环境的变化

• 为什么成长如此困难？
• The Strategic Imperative 8（TM）
• 主要策略要务对 OSD 製剂产业的影响

生态系统

• 分析范围
• 行业定义和细分
• 定义 - 基于 API 发射曲线的 OSD

成长发电机

• 生长促进因子
• 成长抑制因素

成长环境

• 开发平臺和产品创新
• 小分子口服製剂产业概况
• 小分子 OSD 製剂（依治疗领域）
• 小分子OSD製剂的治疗领域与剂型

锭剂和胶囊产业—创新和新兴趋势

• 缓释性剂型的创新
• 产业趋势和新兴技术

锭剂和胶囊产业-地区政策法规的影响

• 区域政策与倡议

锭剂和胶囊行业 - 製造和 CDMO 行业概述

• OSD製造-製造流程
• 供应商生态系统
• 小分子OSD CDMO产业收益
• OSD CDMO产业概况
• 供应链弹性策略—重点领域

锭剂和胶囊行业 - 影响成长主题的投资和整合趋势

• 投资趋势 - 扩张和能力建设
• 整合趋势－併购
• 成长主题和经营模式

锭剂和胶囊产业－基于差异化技术和服务的公司基准化分析

• 企业基准化分析-口服给药解决方案与服务
• 企业基准化分析分析
• 特色企业

成长机会宇宙

• 成长机会1：慢性病固定剂量复方产品
• 成长机会2：医用大麻二酚
• 成长机会三：孤儿药阶段性服务
• 成长机会 4：个人化医疗的积层製造

最佳实践意识

• 最佳实践意识

弗罗斯特雷达

• Frost Radar

下一步

Personalized Medicine and Drug Delivery Technologies Enhance Future Growth Potential

This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It identifies the most prevalent and emerging business models supporting industry stakeholders in enhancing their competitiveness and service offerings. Discussions on key industry drivers and restraints, partnerships, investment and consolidation activities, disruptive technologies, recent excipient advancements, and present and future trends shed light on the industry's growth potential. Industry use cases will provide brief insights into game-changing participants working toward developing disruptive technologies and patient-centric drugs. The analysis will also help uncover growth opportunities based on megatrends and business models, clinical needs, use cases, market access strategies, and technology trends.

Research Highlights:

• Impact of strategic imperatives on the industry 
• Growth drivers and restraints 
• Oral solid dosage based on API release profile
• R&D pipeline and product innovations
• Small molecule oral dosage market overview
• Small molecule oral solid dosage formulation by therapy area
• Innovations in extended-release dosage forms
• Industry trends and emerging technologies
• Supply chain resilience strategies – focus areas
• Investment trends – Expansion and capability-building initiatives
• Consolidation trends – mergers & acquisitions
• company benchmarking
• oral drug delivery solutions & services
• Growth opportunities

Table of Contents

Transformation Impacting the Oral Solid Dosage Formulation Growth Environment

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Oral Solid Dosage Formulation Industry

Ecosystem

• Scope of Analysis
• Industry Definition and Segmentation
• Definition-OSD Based on API Release Profile

Growth Generator

• Growth Drivers
• Growth Restraints

Growth Environment

• R&D Pipeline and Product Innovations
• Small Molecule Oral Dosage Formulation Industry Overview
• Small Molecule OSD Formulation by Therapy Area
• Small Molecule OSD Formulation Therapy Area by Dosage Form

Tablet and Capsule Industry-Innovations and Emerging Trends

• Innovations in Extended Release Dosage forms
• Industry Trends and Emerging Technologies

Tablet and Capsule Industry-Regional Policies and Regulatory Impact

• Regional Policies and Initiatives

Tablet and Capsule Industry-Manufacturing and CDMO Industry Overview

• OSD Manufacturing-Production Flow
• Vendor Ecosystem
• Small Molecule OSD CDMO Industry Revenue
• OSD CDMO Industry Overview
• Supply Chain Resilience Strategies-Focus Areas

Tablet and Capsule Industry-Investment and Consolidation Trends Impacting Growth Themes

• Investment Trends-Expansion and Capability Building
• Consolidation Trends-Mergers & Acquisitions
• Growth Themes and Business Models

Tablet and Capsule Industry-Company Benchmarking based on Differentiated Technologies and Services

• Company Benchmarking-Oral Drug Delivery Solutions and Services
• Company Benchmarking Analysis
• Companies to Watch

Growth Opportunity Universe

• Growth Opportunity 1: Fixed Dose Combination Products for Chronic Diseases
• Growth Opportunity 2: Medical Cannabidiol
• Growth Opportunity 3: Phase-appropriate Services for Orphan Drugs
• Growth Opportunity 4: Additive Manufacturing for Personalized Medicine

Best Practices Recognition

• Best Practices Recognition

Frost Radar

• Frost Radar

Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• Take the Next Step
• List of Exhibits
• Legal Disclaimer